In the world of cancer treatment, time matters, not just in diagnosis, but in every hospital visit. Now, for many living with cancer, a new development brings relief, hope, and a lot more comfort. The NHS has introduced a cancer injection called nivolumab, which promises to transform how patients receive immunotherapy. And England is the…
A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a therapy reserved for the ultra-rich. But Chinese biotech start-ups are aiming to change that – by designing cancer therapy for a fraction of the cost and also taking on Western pharmaceutical giants in the process. Beijing-based Likang…
A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it one step closer to offering patients an alternative to antiretroviral therapy, and eventually a functional cure for the virus that causes Aids. Developed by Immuno Cure, based in Hong Kong Science Park, ICVAX demonstrated “exceptional…